Product Wiki · Recalls · Health Canada — Medical Devices

MTS A/B/D Monoclonal and Reverse Grouping Card — recall 48560

Health Canada — Medical Devices · Canada · 2012-12-10 · Type III

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →

Agency: Health Canada — Medical Devices
Recall identifier: 48560
Date of alert: 2012-12-10
Country / jurisdiction: Canada
Risk level: Type III
Risk type: recall
Product category: Medical devices
Product type: Medical devices
Notice status: Archived by the issuing authority — kept for reference

Reported risk: OCD has received complaints of an incomplete foil seal for specific lots of ID -Micro Typing System gel cards. Our investigation confirmed that some MTS gel cards exhibited a weaker or a loose foil seal resulting in the potential for drying of the first microtube. Using gel cards that exhibit drying in microtube(s) may cause false positive reactions leading to erroneous results.

Primary source: https://recalls-rappels.canada.ca/en/alert-recall/mts-abd-monoclonal-and-reverse

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.

MTS A/B/D Monoclonal and Reverse Grouping Card — recall 48560

Related